Foreign General Health Latest World

Scientists In Israel To Announce The Completion Of Covid-19 Vaccine

Scientists in Israel are expected to announce in the coming days that they have completed the development of a vaccine for the new coronavirus COVID-19.

Quoting medical sources, Israeli daily Ha’aretz, reported on Thursday that scientists at the Israel’s Institute for Biological Research, supervised by the Prime Minister’s office, have recently had a significant breakthrough in understanding the biological mechanism and qualities of the virus, including better diagnostic capability, production of antibodies for those who already have the coronavirus and development of a vaccine.

The development process, however, requires a series of tests and experiments that may last many months before the vaccination is deemed effective or safe to use, the report said.

The Defence Ministry, however, did not confirm the same in its response to the daily.

“There has been no breakthrough in the efforts of the biological institute to find a vaccine for the coronavirus or to develop testing kits. The institute’s work is conducted according to an orderly work plan and it will take time. If and when there will be something to report, it will be done in an orderly fashion”, the Defence Ministry told Ha’aretz.

“The biological institute is a world-renowned research and development agency, which relies on experienced researchers and scientists with great knowledge and quality infrastructures. There are now more than 50 experienced scientists working at the institute on researching and developing a medical remedy for the virus,” it added.

Experts believe that the length of time needed to develop a vaccine runs from a few months to a year and a half.

Numerous research teams all over the world are participating in the race to develop a vaccine for COVID-19. Many of them at this point is focusing on the way the virus presents itself in animals, with the biggest hurdle being the way it morphs when it moves from animals to human beings.

 

Topics

Connect With US




Loading…